This is an example showing trial design and results data of Study #8325064 for the determination of the in vitro bacterial reverse mutation test potential of 10 tobacco products in the in vitro Micronucleus Assay
The bacterial reverse mutation test uses amino acid-requiring strains of Salmonella typhimurium (S. typhimurium) and Escherichia coli (E. coli) to detect point mutations, which involve substitution, addition or deletion of one or a few DNA base pairs. The principle of this bacterial reverse mutation test is that it detects chemicals that induce mutations which revert mutations present in the tester strains and restore the functional capability of the bacteria to synthesize an essential amino acid. The revertant bacteria are detected by their ability to grow in the absence of the amino acid required by the parent tester strain.
Plate number
red font - indicates potential for CT code lists
green font - links to other domains
purple font - to be discussed
Assumption: The intent of this dataset is to provide a summary of trial (study) information. This is not subject-level data.
What is the best ASSAYID, Species, Test System, GLP?
Row
STUDYID
ASSAYID
DOMAIN
TSSEQ
TSGRPID
TSPARMCD
TSPARM
TSVAL
TSVALNF
1
8325064
Ames
TS
1
GLPTYP
Good Laboratory Practice Type
FDA
2
8325064
Ames
TS
2
GLPTYP
Good Laboratory Practice Type
OECD
3
8325064
Ames
TS
1
STSTDTC
Study Start Date
2015-07-29
4
TS
1
STITLE
Study Title
Determination of the in vitro genotoxicity potential of 10 tobacco products in the in vitro Micronucleus Assay
5
TS
1
SNDIGVER
SEND Implementation Guide Version
TOBACCO IMPLEMENTATION GUIDE VERSION 1.0
6
TS
1
SNDCTVER
SEND Controlled Terminology Version
SEND Terminology 2021-09-30
7
TS
1
SSPONSOR
Sponsor Organization
Example Sponsor Inc.
8
TS
1
SPREFID
Sponsor's Study Reference ID
NOT APPLICABLE
9
TS
1
1
TSTFNAM
Test Facility Name
Example Tox Lab Name
10
TS
1
1
TSTFLOC
Test Facility Location
10 Somewhere Street, Montgomery, AL 10000
11
TS
1
1
TFCNTRY
Test Facility Country
USA
12
TS
1
1
STDIR
Study Director
Dr. R. Smith
13
TS
1
GLPFL
GLP Flag
N
14
TS
1
ASTD
Assay Standard
OECD Test No. 471
15
123
TS
1
ASTDV
Assay Standard Version
2020-06-29
16
123
TS
1
SSTYP
Study Type
GENOTOXICITY IN VITRO
17
123
TS
1
SSSTYP
Study Sub Type
Bacterial Reverse Mutation Test
18
123
TS
1
SPECIES
Species
Homo Sapiens
19
123
TS
1
??
Test System?
TK6 Lymphoblastoid Suspension Cells
During CT definition/reviews will decide appropriate TXPARM and TXVAL; Treatment duration may be controlled; For now, we just include good example values based on our experience
Assumption: The Trial Sets (TX) domain provides the list of distinct sets of subjects having different experimental factors, treatment factors, inherent characteristics, or distinct sponsor designations as specified in the trial design.
Where is TK6 cell type? is this test system (see below)
needs to be allowed to vary down to the well level / result level
Row
STUDYID
ASSAYID
DOMAIN
SETCD
SET (what sponsor calls it)
TXSEQ
TXPARMCD
TXPARM
TXVAL
8325064
Ames
TX
SetA (TA98-DMSO)
METACT
Metabolic Activation (should there be two parms? Presence, type)?
None
8325064
Ames
TX
SetA
TRTDRTRG
Treatment Duration target. (how do we show 3-6 hour range? start/end, target and tolerance?, one text field not-analyzable)
TX
TRTDRTOL
Treatment Duration Tolerance
TX
TRTDURU
Treatment Duration Unit (this is for both TRTDURT, TRTDURTOL)
TX
INTRVN
name of the intervention article
(Tobacco ProdA, Bleomycin or Cyclophosphamid A)
DMSO
TX
ITVTYPE
type of intervention article
choices of values: product; negative control; positive control
Vehicle Control
TX
ITVCONC
Concentration of intervention article
0
TX
ITVCONCU
Concentration Unit
ug/ml
TX
STRAIN
Strain/Substrain
TA98
TX
REGIME
Smoking Regime
TX
RUN
Assay run number
1
TX
PORT
Port ID
TX
SMPLID
Sample ID
TX
SMKFRC
Smoke Fraction
TX
REPNUM
Replicate Number
MEAN
STDDEV
FOLDINC
TX
P2
METACT
Metabolic Activation (should there be two parms? Presence, type)?
+S9
TX
P2
TRTDRTRG
Treatment Duration target. (how do we show 3-6 hour range? start/end, target and tolerance?, one text field not-analyzable)
3
TX
P2
TRTDRTOL
Treatment Duration Tolerance
TX
P2
TRTDURU
Treatment Duration Unit (this is for both TRTDURT, TRTDURTOL)